When searching to scale, B2B companies often assume they need more sales or more clients. However, during the Atomic Revenue diagnostics phase, we often prove, using meaningful data, that roadblocks may not be where you think they are and that growth can come from very unexpected places, areas that may not be on your company's radar. This is exactly what happened in this case, with TriRinse.
